Global Baculovirus Expression System Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Baculovirus Expression System Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Baculovirus Expression System is a type of protein expression system that uses insect cells and baculoviruses to produce recombinant proteins. This system has become increasingly popular for the expression of eukaryotic proteins that are difficult to produce in other systems, such as bacteria or yeast. Baculovirus Expression System involves the insertion of a gene of interest into a baculovirus genome, which is then used to infect insect cells. The infected cells then produce large quantities of the recombinant protein, which can be purified and used for various applications, such as drug discovery, vaccine development, and protein structure analysis.
Baculovirus Expression System report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Baculovirus Expression System market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Drugs Development and Biomedical Research are the major drivers for the industry.
The global market for Baculovirus Expression System has been witnessing steady growth due to its versatility, high expression levels, and post-translational modifications that closely resemble those in higher eukaryotes. The system finds applications in various fields, including biopharmaceuticals, research, and industrial biotechnology. The United States and Canada have a strong presence in the Baculovirus Expression System market, driven by a robust biopharmaceutical industry and significant investments in research and development. European countries have a prominent role in academic research and industrial applications of the Baculovirus Expression System, with a focus on producing high-value recombinant proteins. Asia-Pacific is experiencing growth in the Baculovirus Expression System market, driven by increasing research activities, biopharmaceutical development, and the expansion of the industrial biotechnology sector. The Baculovirus Expression System market is expected to continue growing as biopharmaceutical companies seek efficient and reliable methods for producing complex proteins. Advances in gene editing technologies and the development of high-yield insect cell lines are likely to further enhance the capabilities of the system. Additionally, the increasing demand for biologics and personalized medicine is expected to drive the adoption of Baculovirus Expression System in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Baculovirus Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Expression Systems
Creative BioMart
Profacgen
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Autographa Californica Multiple Nucleopolyhedrovirus
Bombyx Mori Nucleopolyhedrovirus
Others
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Baculovirus Expression System market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Baculovirus Expression System introduction, etc. Baculovirus Expression System Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Baculovirus Expression System market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Baculovirus Expression System report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Baculovirus Expression System market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Drugs Development and Biomedical Research are the major drivers for the industry.
The global market for Baculovirus Expression System has been witnessing steady growth due to its versatility, high expression levels, and post-translational modifications that closely resemble those in higher eukaryotes. The system finds applications in various fields, including biopharmaceuticals, research, and industrial biotechnology. The United States and Canada have a strong presence in the Baculovirus Expression System market, driven by a robust biopharmaceutical industry and significant investments in research and development. European countries have a prominent role in academic research and industrial applications of the Baculovirus Expression System, with a focus on producing high-value recombinant proteins. Asia-Pacific is experiencing growth in the Baculovirus Expression System market, driven by increasing research activities, biopharmaceutical development, and the expansion of the industrial biotechnology sector. The Baculovirus Expression System market is expected to continue growing as biopharmaceutical companies seek efficient and reliable methods for producing complex proteins. Advances in gene editing technologies and the development of high-yield insect cell lines are likely to further enhance the capabilities of the system. Additionally, the increasing demand for biologics and personalized medicine is expected to drive the adoption of Baculovirus Expression System in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Baculovirus Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Expression Systems
Creative BioMart
Profacgen
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Autographa Californica Multiple Nucleopolyhedrovirus
Bombyx Mori Nucleopolyhedrovirus
Others
Segment by Application
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Baculovirus Expression System market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Baculovirus Expression System introduction, etc. Baculovirus Expression System Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Baculovirus Expression System market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices